🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsGLP-1/GIP receptor co-agonism — my results so far Page 3

GLP-1/GIP receptor co-agonism — my results so far

rick_sfbay Tue, Nov 25, 2025 at 1:20 PM 13 replies 1,115 viewsPage 3 of 3
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Nov 29, 2025 at 7:43 AM#11
Dr.Martinez said:
The mechanism is more central than most summaries suggest.

Agreed, and the adaptation point cuts both ways: tachyphylaxis to gastric emptying is why tolerability improves, and it is also why people who were relying on physical fullness feel the effect fade while the appetite effect is still working.

That is the short version; the long version is somebody else's post.

39 12anna.melb_AU, mark_tokyo, hans_munich and 36 others
Reply Quote Save Share Report
marcus_mpls
Member
234
1,123
Nov 2024
Minneapolis, MN
Nov 29, 2025 at 3:45 PM#12
ZaraB_AL said:
True, though the ladder is longer and that is not a neutral detail — six dose steps means six opportunities to stall on the way up, and plenty of…

That reframing is the part I needed. Adding it to my notes with a link back to this thread.

40 13oliver_london, tane_welly, Dr.PathRoch and 37 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Nov 29, 2025 at 11:47 PM#13
Dr.Martinez said:
The mechanism is more central than most summaries suggest.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

Last edited: Nov 30, 2025 at 12:47 AM
41 14COA_Karl, MikeFit_NJ, InsuranceTom and 38 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Nov 30, 2025 at 7:49 AM#14

Adding the numbers, since they settle part of this. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

Worth separating that from the pharmacology, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

42 15FranDenver, Dr.BariatricHTX, LindaRN_retired and 39 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Nov 30, 2025 at 3:51 PM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. No action needed from anybody.

Last edited: Nov 30, 2025 at 7:51 PM
43 16PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 40 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register